On 2025-05-06, Spruce Biosciences, Inc. (SPRBD) announced earnings per share of $-24.06 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-18.80.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-19.17 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2025-05-06 | 2025-03-31 | $-18.80 | $-24.06 |
2025-04-15 | 2024-12-31 | -- | $-42.86 |
2024-11-11 | 2024-09-30 | $-20.30 | $-15.79 |
2024-08-12 | 2024-06-30 | $-24.81 | $-16.54 |
2024-05-13 | 2024-03-31 | $-24.06 | $-21.05 |
2024-03-13 | 2023-12-31 | $-30.83 | $-17.29 |
2023-11-13 | 2023-09-30 | $-25.56 | $-22.56 |
2023-08-14 | 2023-06-30 | $-27.82 | $-24.06 |
2023-05-15 | 2023-03-31 | $-31.58 | $-30.08 |
2023-03-16 | 2022-12-31 | $-41.35 | $-35.34 |
2022-11-10 | 2022-09-30 | $-40.60 | $-36.09 |
2022-08-10 | 2022-06-30 | $-40.60 | $-38.35 |
2022-05-11 | 2022-03-31 | $-33.83 | $-37.59 |
2022-03-14 | 2021-12-31 | $-42.86 | $-29.32 |
2021-11-15 | 2021-09-30 | $-42.86 | $-36.84 |
2021-08-10 | 2021-06-30 | $-33.83 | $-37.59 |
2021-05-12 | 2021-03-31 | $-33.08 | $-31.58 |
2021-03-22 | 2020-12-31 | $-45.11 | $-29.32 |
2020-11-18 | 2020-09-30 | $-121.80 | $-928.57 |